Moneycontrol PRO
HomeNewsBusinessMarketsCaplin Point Labs Chennai plant to be inspected by FDA in Oct

Caplin Point Labs Chennai plant to be inspected by FDA in Oct

Drug firm Caplin Point Laboratories today said US health regulator would conduct a prior approval inspection of its Gummidopoondi facility in Chennai in October.

September 10, 2016 / 10:04 IST

Drug firm Caplin Point Laboratories today said US health regulator would conduct a prior approval inspection of its Gummidopoondi facility in Chennai in October.

"The United States Food and Drug Administration (USFDA) inspection is to be conducted for the company's sterile injectable site located near Gummidopoondi in third week of October," Caplin Point Laboratories said in a filing to BSE.

This Prior Approval Inspection (PAI) is in relation to an injectable product abbreviated new drug application (ANDA) being submitted with USFDA, it added.

The company holds over 2,000 product licenses across the globe.

Shares of Caplin Point Laboratories today closed at Rs 1,315.05 on BSE, down 0.55 per cent from its previous close.

first published: Sep 9, 2016 08:20 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347